Literature DB >> 6630362

Gradient optimization principles in reversed-phase high-performance liquid chromatography and the separation of influenza virus components.

M A Phelan, K A Cohen.   

Abstract

Reversed-phase high-performance liquid chromatography is used to separate the major proteins of A/Bangkok/1/79 X 73 influenza virus. The purity of the isolated proteins, their yield and reactivity with monoclonal antibodies are discussed. The virus, in turn, is used as a probe to examine some theoretical gradient principles relating resolution, retention time and gradient time. Empirical compliance with these principles is generally shown.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630362     DOI: 10.1016/s0021-9673(01)90879-9

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

Review 1.  Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages.

Authors:  Petra Kramberger; Lidija Urbas; Aleš Štrancar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine.

Authors:  Anastasija Shytuhina; Pavlo Pristatsky; Jian He; Danilo R Casimiro; Richard M Schwartz; Van M Hoang; Sha Ha
Journal:  J Chromatogr A       Date:  2014-06-19       Impact factor: 4.759

3.  Isolation by high-performance liquid chromatography and partial characterization of a 57,000-dalton herpes simplex virus type 1 polypeptide.

Authors:  S Welling-Wester; T Popken-Boer; J B Wilterdink; J van Beeumen; G W Welling
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

Review 4.  Column liquid chromatography of integral membrane proteins.

Authors:  G W Welling; R van der Zee; S Welling-Wester
Journal:  J Chromatogr       Date:  1987-07-17

5.  A novel synthetic receptor-based immunoassay for influenza vaccine quantification.

Authors:  Anwar M Hashem; Caroline Gravel; Aaron Farnsworth; Wei Zou; Michelle Lemieux; Kangwei Xu; Changgui Li; Junzhi Wang; Marie-France Goneau; Maria Merziotis; Runtao He; Michel Gilbert; Xuguang Li
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

6.  Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.

Authors:  Kangwei Xu; Changgui Li; Caroline Gravel; Zheng Jiang; Bozena Jaentschke; Gary Van Domselaar; Xuguang Li; Junzhi Wang
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.